ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 43 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $583,000 | -6.1% | 575,000 | 0.0% | 0.00% | – |
Q4 2020 | $621,000 | +4.4% | 575,000 | 0.0% | 0.00% | – |
Q3 2020 | $595,000 | -6.2% | 575,000 | 0.0% | 0.00% | – |
Q2 2020 | $634,000 | -84.0% | 575,000 | -85.4% | 0.00% | -100.0% |
Q1 2020 | $3,973,000 | -42.8% | 3,925,000 | -35.4% | 0.00% | 0.0% |
Q4 2019 | $6,951,000 | +0.3% | 6,075,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $6,929,000 | +919.0% | 6,075,000 | +956.5% | 0.00% | – |
Q2 2019 | $680,000 | -89.8% | 575,000 | -88.3% | 0.00% | -100.0% |
Q1 2019 | $6,671,000 | +26.3% | 4,935,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $5,281,000 | +13.4% | 4,935,000 | +11.3% | 0.00% | +100.0% |
Q3 2018 | $4,657,000 | -56.8% | 4,435,000 | -59.6% | 0.00% | -75.0% |
Q2 2018 | $10,783,000 | +8.3% | 10,975,000 | +8.9% | 0.00% | 0.0% |
Q1 2018 | $9,953,000 | -18.5% | 10,075,000 | -13.0% | 0.00% | 0.0% |
Q4 2017 | $12,219,000 | -0.1% | 11,575,000 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $12,226,000 | +0.2% | 11,575,000 | +0.7% | 0.01% | +25.0% |
Q2 2017 | $12,197,000 | +10.1% | 11,500,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $11,076,000 | -4.5% | 11,500,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $11,593,000 | +8.3% | 11,500,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $10,702,000 | +31.7% | 11,500,000 | 0.0% | 0.00% | +33.3% |
Q2 2016 | $8,129,000 | -40.4% | 11,500,000 | -23.3% | 0.00% | -50.0% |
Q1 2016 | $13,650,000 | -19.1% | 15,000,000 | 0.0% | 0.01% | -14.3% |
Q4 2015 | $16,875,000 | – | 15,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|